July 2, 2012 — Researchers have announced the results of a study that shows the utility of a six minute walk stress echocardiogram for the early detection of exercise-induced pulmonary arterial hypertension (EIPAH) in patients with connective tissue disease (CTD). Earlier treatment of these patients may improve the prognosis for CTD, as those who develop EIPAH may be at risk for resting pulmonary arterial hypertension (PAH) in the future.

A poster based on the study will be presented on Sunday, July 1 from 9:30 a.m. to 4:30 p.m. in the exhibit and poster hall during the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions. Investigators will be available in the hall from 12:15 p.m. to 1:45 p.m. The ASE Scientific Sessions will be held from June 27 to July 3, 2012, at the Gaylord National in National Harbor, MD.

“Doppler echocardiography is currently the recommended screening modality to diagnose PAH; however, in about two-thirds of cases, the pulmonary vascular bed had been already impaired in patients diagnosed to have PAH at rest. To diagnose PAH earlier, it is helpful to detect exercise-induced PAH (EIPAH) by stress echocardiography. Our study shows the efficacy of 6-minute walk stress echocardiography for this purpose. In our study, we were able to detect EIPAH in CTD patients who did not have PAH when at rest. Six-minute walk stress echocardiography is an easy, inexpensive and useful tool for detecting EIPAH, which could be very early-stage PAH,” said primary investigator Junko Hotchi.

Hirotsugu Yamada, Susumu Nishio, Noriko Tomita, Shuji Hayashi, Mika Bando, Rina Tamai, Maya Nakagawa, Daichi Hirota, Yukina Hirata, Kozue Ogasawara, Sachiko Bando, Takayuki Ise, Toshiyuki Niki, Koji Yamaguchi, Yoshio Taketani, Takashi Iwase, Takeshi Soeki, Tetsuzo Wakatsuki, and Masataka Sata, all of Tokushima University Hospital, Tokushima, Japan, and Kenya Kusunose of the Cleveland Clinic, Cleveland, were also part of the team that conducted the study, which found EIPAH in 29 out of a 109 patient study group.

For more information: www.asecho.org


Related Content

News | FDA

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed ...

Time July 08, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Focused Ultrasound Therapy

Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...

Time January 08, 2025
arrow
Subscribe Now